OppenheimerFunds’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$16.3M	Buy	183,254 +7,735	+4%	+$717K	0.02%	583
2018 Q4	$14.9M	Sell	175,519 -2,612	-1%	-$248K	0.02%	579
2018 Q3	$17.3M	Hold	178,131	–	–	0.02%	621
2018 Q2	$16.8M	Sell	178,131 -1,083,831	-86%	-$94.9M	0.02%	625
2018 Q1	$102M	Sell	1,261,962 -55,172	-4%	-$4.73M	0.13%	175
2017 Q4	$117M	Sell	1,317,134 -31,239	-2%	-$2.72M	0.14%	166
2017 Q3	$125M	Sell	1,348,373 -239,577	-15%	-$21.2M	0.15%	155
2017 Q2	$144M	Sell	1,587,950 -81,407	-5%	-$7.41M	0.18%	144
2017 Q1	$147M	Sell	1,669,357 -10,020	-0.6%	-$891K	0.18%	148
2016 Q4	$139M	Sell	1,679,377 -484,776	-22%	-$41.7M	0.18%	145
2016 Q3	$200M	Buy	2,164,153 +95,140	+5%	+$8.96M	0.25%	111
2016 Q2	$161M	Buy	2,069,013 +201,629	+11%	+$17.1M	0.21%	127
2016 Q1	$154M	Buy	1,867,384 +152,696	+9%	+$12.4M	0.2%	126
2015 Q4	$180M	Sell	1,714,688 -120,150	-7%	-$12.5M	0.23%	109
2015 Q3	$193M	Sell	1,834,838 -78,910	-4%	-$10.5M	0.26%	101
2015 Q2	$262M	Sell	1,913,748 -4,190	-0.2%	-$519K	0.3%	88
2015 Q1	$239M	Buy	1,917,938 +150,530	+9%	+$15.9M	0.27%	107
2014 Q4	$160M	Sell	1,767,408 -62,440	-3%	-$5.19M	0.18%	155
2014 Q3	$132M	Buy	1,829,848 +1,345,578	+278%	+$88.4M	0.15%	179
2014 Q2	$30.1M	Sell	484,270 -29,070	-6%	-$1.76M	0.03%	475
2014 Q1	$35M	Buy	513,340 +245,040	+91%	+$18.1M	0.04%	428
2013 Q4	$18.9M	Buy	268,300 +175,630	+190%	+$11.9M	0.02%	575
2013 Q3	$6.69M	Sell	92,670 -130	-0.1%	-$8.64K	0.01%	779
2013 Q2	$5.18M	Buy	+92,800	New	+$5.78M	0.01%	784